KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-cash Items (2016 - 2017)

Historic Non-cash Items for Neogenomics (NEO) over the last 4 years, with Q4 2017 value amounting to $5.1 million.

  • Neogenomics' Non-cash Items fell 86.27% to $5.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $5.1 million, marking a year-over-year decrease of 86.27%. This contributed to the annual value of $5.1 million for FY2017, which is 86.27% down from last year.
  • As of Q4 2017, Neogenomics' Non-cash Items stood at $5.1 million, which was down 86.27% from $2.1 million recorded in Q3 2017.
  • Neogenomics' 5-year Non-cash Items high stood at $5.1 million for Q4 2016, and its period low was $900000.0 during Q1 2015.
  • In the last 4 years, Neogenomics' Non-cash Items had a median value of $3.0 million in 2015 and averaged $3.1 million.
  • As far as peak fluctuations go, Neogenomics' Non-cash Items surged by 30508.33% in 2015, and later plummeted by 86.27% in 2017.
  • Over the past 4 years, Neogenomics' Non-cash Items (Quarter) stood at $1.2 million in 2014, then skyrocketed by 305.08% to $4.9 million in 2015, then rose by 4.92% to $5.1 million in 2016, then decreased by 0.86% to $5.1 million in 2017.
  • Its Non-cash Items was $5.1 million in Q4 2017, compared to $2.1 million in Q3 2017 and $5.1 million in Q4 2016.